-
Symbol
-
YMAB
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
0 shares
-
Security Ownership %
-
0%
Glazer Capital, LLC ownership in Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value per share (YMAB)
13 Nov 2025 - Glazer Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value per share (YMAB).
This represents 0% ownership of the company.
In their previous filing dated 15 Aug 2025, GLAZER CAPITAL, LLC had reported owning 2,654,700 shares, indicating a decrease of +100%.
.